Cargando…

Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis

BACKGROUND: Continuous ambulatory peritoneal dialysis (CAPD) patients have a high incidence of stroke and commonly have increased parathyroid hormone levels and vitamin D insufficiency. We seek to investigate the incidence of stroke and the role of parathyroid hormone and vitamin D supplementation i...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Xiaohan, Zhou, Ying, Zhang, Jianna, Zhou, Qiongxiu, Shi, Yanling, Su, Zhen, Chen, Chaoshen, Shao, Rongrong, Zhang, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236177/
https://www.ncbi.nlm.nih.gov/pubmed/32423377
http://dx.doi.org/10.1186/s12882-020-01817-6
_version_ 1783536109627637760
author You, Xiaohan
Zhou, Ying
Zhang, Jianna
Zhou, Qiongxiu
Shi, Yanling
Su, Zhen
Chen, Chaoshen
Shao, Rongrong
Zhang, Ji
author_facet You, Xiaohan
Zhou, Ying
Zhang, Jianna
Zhou, Qiongxiu
Shi, Yanling
Su, Zhen
Chen, Chaoshen
Shao, Rongrong
Zhang, Ji
author_sort You, Xiaohan
collection PubMed
description BACKGROUND: Continuous ambulatory peritoneal dialysis (CAPD) patients have a high incidence of stroke and commonly have increased parathyroid hormone levels and vitamin D insufficiency. We seek to investigate the incidence of stroke and the role of parathyroid hormone and vitamin D supplementation in stroke risk among CAPD patients. METHODS: This study employed a retrospective design. We enrolled a Chinese cohort of 980 CAPD patients who were routinely followed in our department. The demographic and clinical data were recorded at the time of initial CAPD and during follow-up. The included patients were separated into non-stroke and stroke groups. The effects of parathyroid hormone and vitamin D supplementation on stroke in CAPD patients was evaluated. The primary endpoint is defined as the first occurrence of stroke, and composite endpoint events are defined as death or switch to hemodialysis during follow-up. RESULTS: A total of 757 eligible CAPD patients with a mean follow-up time of 54.7 (standard deviation, 33) months were included in the study. The median incidence of stroke among our CAPD patients was 18.9 (interquartile range, 15.7–22.1) per 1000 person-years. A significant nonlinear correlation between baseline iPTH and hazard of stroke (p-value of linear association = 0.2 and nonlinear association = 0.002) was observed in our univariate Cox regression analysis, and low baseline iPTH levels (≤150 pg/ml) were associated with an increased cumulative hazard of stroke. Multivariate Cox regression analysis indicated a significant interaction effect between age and iPTH after adjusting for other confounders. Vitamin D supplementation during follow-up was a predictive factor for stroke in our cohort. CONCLUSIONS: CAPD patients suffered a high risk of stroke, and lower iPTH levels were significantly correlated with an increased risk of stroke. Nevertheless, vitamin D supplementation may reduce the risk of stroke in these patients.
format Online
Article
Text
id pubmed-7236177
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72361772020-05-27 Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis You, Xiaohan Zhou, Ying Zhang, Jianna Zhou, Qiongxiu Shi, Yanling Su, Zhen Chen, Chaoshen Shao, Rongrong Zhang, Ji BMC Nephrol Research Article BACKGROUND: Continuous ambulatory peritoneal dialysis (CAPD) patients have a high incidence of stroke and commonly have increased parathyroid hormone levels and vitamin D insufficiency. We seek to investigate the incidence of stroke and the role of parathyroid hormone and vitamin D supplementation in stroke risk among CAPD patients. METHODS: This study employed a retrospective design. We enrolled a Chinese cohort of 980 CAPD patients who were routinely followed in our department. The demographic and clinical data were recorded at the time of initial CAPD and during follow-up. The included patients were separated into non-stroke and stroke groups. The effects of parathyroid hormone and vitamin D supplementation on stroke in CAPD patients was evaluated. The primary endpoint is defined as the first occurrence of stroke, and composite endpoint events are defined as death or switch to hemodialysis during follow-up. RESULTS: A total of 757 eligible CAPD patients with a mean follow-up time of 54.7 (standard deviation, 33) months were included in the study. The median incidence of stroke among our CAPD patients was 18.9 (interquartile range, 15.7–22.1) per 1000 person-years. A significant nonlinear correlation between baseline iPTH and hazard of stroke (p-value of linear association = 0.2 and nonlinear association = 0.002) was observed in our univariate Cox regression analysis, and low baseline iPTH levels (≤150 pg/ml) were associated with an increased cumulative hazard of stroke. Multivariate Cox regression analysis indicated a significant interaction effect between age and iPTH after adjusting for other confounders. Vitamin D supplementation during follow-up was a predictive factor for stroke in our cohort. CONCLUSIONS: CAPD patients suffered a high risk of stroke, and lower iPTH levels were significantly correlated with an increased risk of stroke. Nevertheless, vitamin D supplementation may reduce the risk of stroke in these patients. BioMed Central 2020-05-18 /pmc/articles/PMC7236177/ /pubmed/32423377 http://dx.doi.org/10.1186/s12882-020-01817-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
You, Xiaohan
Zhou, Ying
Zhang, Jianna
Zhou, Qiongxiu
Shi, Yanling
Su, Zhen
Chen, Chaoshen
Shao, Rongrong
Zhang, Ji
Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title_full Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title_fullStr Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title_full_unstemmed Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title_short Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
title_sort effects of parathyroid hormone and vitamin d supplementation on stroke among patients receiving peritoneal dialysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236177/
https://www.ncbi.nlm.nih.gov/pubmed/32423377
http://dx.doi.org/10.1186/s12882-020-01817-6
work_keys_str_mv AT youxiaohan effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT zhouying effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT zhangjianna effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT zhouqiongxiu effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT shiyanling effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT suzhen effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT chenchaoshen effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT shaorongrong effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis
AT zhangji effectsofparathyroidhormoneandvitamindsupplementationonstrokeamongpatientsreceivingperitonealdialysis